Literature DB >> 1649212

Absence of detectable immunoreactive alpha melanocyte stimulating hormone in plasma in various types of Cushing's disease.

R J Croughs1, J H Thijssen, J A Mol.   

Abstract

We have measured alpha-MSH in plasma of normal subjects and subjects with various diseases of the pituitary-adrenocortical system using a radioimmunoassay with a sensitivity of 1.2 pmol/l. No alpha-MSH could be detected in plasma of normal subjects (n = 6), in plasma of patients with Addison's disease (n = 3), Nelson's syndrome (n = 2), bromocriptine responsive (n = 2) and unresponsive (n = 5) Cushing's disease and in plasma of psychiatric patients on chronic treatment with the dopamine antagonist haloperidol (n = 5). Plasma alpha-MSH remained undetectable in 2 patients with Cushing's disease after iv injection of 60 micrograms/kg haloperidol. In contrast, alpha-MSH was detectable in plasma of normal dogs (n = 2) and dogs with pituitary dependent hyperadrenocorticism (n = 2), whereas the iv injection of halo peridol was associated with a rise of plasma alpha-MSH. Thus we are unable to detect circulating alpha-MSH in man despite the use of a sensitive radioimmunoassay.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1649212     DOI: 10.1007/BF03346788

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  14 in total

1.  Response to neurotransmitter modulating drugs in patients with Cushing's disease.

Authors:  H P Koppeschaar; R J Croughs; J H Thijssen; F Schwarz
Journal:  Clin Endocrinol (Oxf)       Date:  1986-12       Impact factor: 3.478

2.  The distribution of immunoreactive alpha-melanocyte-stimulating hormone cells in the adult human pituitary gland.

Authors:  P J Coates; I Doniach; A C Hale; L H Rees
Journal:  J Endocrinol       Date:  1986-11       Impact factor: 4.286

3.  Adrenocorticotropin-secreting pituitary adenomas originate from the anterior or the intermediate lobe in Cushing's disease: differences in the regulation of hormone secretion.

Authors:  S W Lamberts; S A de Lange; S Z Stefanko
Journal:  J Clin Endocrinol Metab       Date:  1982-02       Impact factor: 5.958

4.  In vivo evidence for dopaminergic regulation of the canine pituitary intermediate lobe.

Authors:  R J Kemppainen; J L Sartin
Journal:  Acta Endocrinol (Copenh)       Date:  1986-12

5.  Plasma immunoreactive proopiomelanocortin peptides and cortisol in normal dogs and dogs with Addison's disease and Cushing's syndrome: basal concentrations.

Authors:  M E Peterson; D N Orth; N S Halmi; A C Zielinski; D R Davis; F T Chavez; W D Drucker
Journal:  Endocrinology       Date:  1986-08       Impact factor: 4.736

6.  Peptides related to alpha-melanocyte-stimulating hormone are commonly produced by human pituitary corticotroph adenomas: no relationship with pars intermedia origin.

Authors:  P J Coates; I Doniach; C Wells; A C Hale; L H Rees; G M Besser
Journal:  J Endocrinol       Date:  1989-03       Impact factor: 4.286

7.  Effects of bromocriptine on corticotrophin, melanotrophin and corticosteroid secretion in dogs with pituitary-dependent hyperadrenocorticism.

Authors:  A Rijnberk; J A Mol; M M Kwant; R J Croughs
Journal:  J Endocrinol       Date:  1988-08       Impact factor: 4.286

8.  Results of cyproheptadine treatment in dogs with pituitary-dependent hyperadrenocorticism.

Authors:  R Stolp; R J Croughs; A Rijnberk
Journal:  J Endocrinol       Date:  1984-06       Impact factor: 4.286

9.  Increased production of alpha-melanocyte-stimulating hormone in the pituitary gland of patients with untreated Addison's disease.

Authors:  P J Coates; A M McNicol; I Doniach; L H Rees
Journal:  Clin Endocrinol (Oxf)       Date:  1988-10       Impact factor: 3.478

10.  A direct radioimmunoassay for the determination of adrenocorticotropic hormone (ACTH) and a clinical evaluation.

Authors:  C J Arts; H P Koppeschaar; W Veeman; J H Thijssen
Journal:  Ann Clin Biochem       Date:  1985-05       Impact factor: 2.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.